Global Cardiovascular Health
Global Health, Public Health, Cardiometabolic Disease
Research aim
To study cardiovascular risk factors and health outcomes; and develop, implement and scale-up cost-efficient approaches for primary and secondary prevention of cardiovascular disease to promote equity in cardiovascular health globally.
About us
Cardiovascular disease is the leading cause of mortality worldwide, increasingly affecting populations in low- and middle-income countries. This increase has been attributed to population aging and trends towards unhealthy diets, smoking and sedentary lifestyles, in part related to increasing urbanization and globalization.
Global Cardiovascular Health undertakes research on cardiovascular risk (CV) factors and disease outcomes and clinical trials to test the effectiveness and impact of evidence-based interventions on CV health in partnership with academic and health care organisations globally.
Recent projects include:
- ‘SUrvey of Risk Factors’ (SURF) study assesses CV factor recording and management globally to improve standard of care in daily practice and cardiovascular health outcomes;
- ‘Scale-Up Diabetes and hYpertension care’ (SCUBY) study assessed the impact of scaling-up an integrated chronic care package on hypertension and diabetes outcomes in Asia and Europe;
- ‘Integration HIV and hEART health in South Africa’ (iHEART-South Africa) study investigates innovations for hypertension management that are tested to expand the scope of care in a sustainable, scalable, and impactful way;
- ‘CAPacity Strengthening of Transdisciplinary education for nON-communicable disease care in West-Africa’ (CAPSTONE) to build health professionals capacity in non-communicable diseases in higher education institutions in West Africa.
For further information please see Global Health Website and Global Health Magazine 2023.